Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (501-510 of 622) with videos related to

Pageof 63
Sort By:
Rheumatology (Oxford, England)|July 30, 2020
cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosisJulie C Worrell, Jack Leslie, Graham R Smith, et al.
Rheumatology (Oxford, England)|October 31, 2022
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritisR Naveen, Ioannis Parodis, Mrudula Joshi, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Rheumatology (Oxford, England)|January 18, 2015
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR populationEric Hachulla, Pierre Clerson, Paolo Airò, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
The Journal of Clinical Investigation|July 1, 2020
Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosisElena Pachera, Shervin Assassi, Gloria A Salazar, et al.
Cardiovascular Research|January 23, 2021
TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodiesAlexander Akhmedov, Margot Crucet, Branko Simic, et al.
Pageof 63

Showing results (501-510 of 622) with videos related to

Sort By:
Pageof 63
Rheumatology (Oxford, England)|July 30, 2020
cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosisJulie C Worrell, Jack Leslie, Graham R Smith, et al.
Rheumatology (Oxford, England)|October 31, 2022
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritisR Naveen, Ioannis Parodis, Mrudula Joshi, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Rheumatology (Oxford, England)|January 18, 2015
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR populationEric Hachulla, Pierre Clerson, Paolo Airò, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Annals of the Rheumatic Diseases|April 24, 2026
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025Kevin L Winthrop, Andreas Kerschbaumer, John D Isaacs, et al.
The Journal of Clinical Investigation|July 1, 2020
Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosisElena Pachera, Shervin Assassi, Gloria A Salazar, et al.
Cardiovascular Research|January 23, 2021
TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodiesAlexander Akhmedov, Margot Crucet, Branko Simic, et al.
Pageof 63